This morning, Johnson & Johnson shared its second-quarter 2026 earnings report.
Since its founding in 1886, the company has been committed to innovation—today, approximately 140,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.
“Our second-quarter performance underscores the breadth and depth of Johnson & Johnson’s portfolio,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “With leading in-market brands, meaningful new products, a robust pipeline and strong financial flexibility, we are well-positioned to invest in transformative innovation to accelerate growth and create sustainable long-term value for shareholders.”
For more details about the company’s second-quarter 2026 results and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
